Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04387435 · ClinicalTrials.gov registry record · NA
Optimization of VNS in Epileptic Patients to Induce Cardioprotection
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04387435 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1 participants.
The verdict
NCT04387435, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is a non-randomized, prospective study in patients with a diagnosis of epilepsy and previously implanted FDA approved Vagus Nerve Stimulation (VNS) devices. The goal of this clinical investigation is to evaluate the effects of adjusting vagus nerve stimulation parameters to engage cardioprotective effects.
Interventions
- OTHER A change or titration in the current or frequency settings of the VNS therapy system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04387435
The ClinicalTrials.gov registry entry for NCT04387435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A change or titration in the current or frequency settings of the VNS therapy system. is the first listed.
NCT04387435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04387435 about?
NCT04387435 is a clinical study titled "Optimization of VNS in Epileptic Patients to Induce Cardioprotection". This study is a non-randomized, prospective study in patients with a diagnosis of epilepsy and previously implanted FDA approved Vagus Nerve Stimulation (VNS) devices. The goal of this clinical investigation is to evaluate the effects of adjusting vagus nerve stimulation parameters to engage cardiop...
What is the current status of trial NCT04387435?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2020-12-01. Estimated completion is 2021-07-07.
What interventions are being tested in trial NCT04387435?
The interventions under investigation include: A change or titration in the current or frequency settings of the VNS therapy system. (OTHER).
Who is sponsoring clinical trial NCT04387435?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.